한글목차

클론 기술 및 돌연변이 유발 기술 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 35억 4,000만 달러에서 2026년에는 42억 1,000만 달러로, CAGR 19.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 학술연구 자금의 확대, 재조합 단백질 연구의 발전, 유전공학 툴의 이용 증가, 표준화된 분자생물학 키트의 보급, 생명공학 스타트업 기업 증가 등이 주요 요인으로 작용한 것으로 보입니다.

클로닝 및 돌연변이 유발 시장의 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 85억 달러에 달하며, CAGR은 19.2%에 달할 전망입니다. 예측 기간 중의 성장세는 유전자 기능 연구에 대한 수요 증가, 합성생물학의 응용 확대, 치료용 단백질 개발에 대한 투자 증가, 자동화 실험 플랫폼의 보급 확대, 정밀 유전체 편집에 대한 집중도 강화 등이 주요 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 고정밀 클로닝 키트 도입 증가, 부위 특이적 돌연변이 도입 기술 활용 확대, CRISPR 기반 편집 툴 수요 증가, 자동화 분자생물학 워크플로우 확대, 재현성 및 정확성에 대한 관심 강화 등을 꼽을 수 있습니다.

복제 및 돌연변이 유도 시장은 맞춤형 의료에 대한 수요 증가로 성장이 예상됩니다. 맞춤형 의료는 환자 개개인의 고유한 특성에 맞게 의료 시술과 개입을 조정하는 혁신적인 의료 접근법입니다. 클로닝과 돌연변이 유도는 질병 모델 구축, 신약 개발, 표적 분자 발굴, 유전자 치료, 바이오마커 발굴, 환자 특이적 세포치료, 약물유전체학, 맞춤 치료를 위한 유전체 편집 등 맞춤의료의 다양한 측면에서 중요한 역할을 합니다. 예를 들어 미국 비영리단체인 '맞춤의료연합'에 따르면 2024년 2월 기준 2023년 FDA는 희귀질환 환자를 위한 16건의 새로운 맞춤치료제를 승인했습니다. 이는 2022년 6건 승인에 비해 크게 증가한 수치입니다. 이러한 맞춤형 의료에 대한 수요 증가는 복제 기술 및 돌연변이 유발 기술 시장의 성장을 촉진하는 중요한 요인입니다.

클론 기술 및 돌연변이 유발 시장의 주요 기업은 경쟁 우위를 유지하기 위해 중합효소 연쇄반응(PCR)과 같은 혁신적인 기술도 적극적으로 모색하고 있습니다. PCR은 특정 DNA 단편을 증폭하는 분자생물학 실험 기술입니다. 미국 바이오테크놀러지 기업인 바이오 래드 래드 래버러토리스(Bio-Rad Laboratories)는 2023년 4월 ID-Check 종별 판별 솔루션을 발표했습니다. 이 실시간 PCR법은 육류 유형 판별을 지원하며, 식품, 사료, 환경 시료에서 동물 종을 식별할 수 있습니다. 원재료의 원산지를 검증하는 신뢰할 수 있고 신속한 수단을 제공하고 생산 라인의 세척 공정을 강화합니다. 이 솔루션은 다양한 육류 종의 미토콘드리아 DNA를 매우 높은 민감도로 표적화하여 0.001%라는 낮은 농도의 DNA도 검출합니다. 정확성과 사용자 편의성을 고려한 이중 감지 시스템이 특징입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cloning and mutagenesis are integral techniques within molecular biology that involve the replication of multiple identical copies of a DNA fragment, gene, or entire genome, along with the introduction of mutations into a DNA sequence. These techniques play a crucial role in studying gene function and regulation, facilitating the development of new drugs and therapeutics, and producing recombinant enzymes and proteins.

The primary products associated with cloning and mutagenesis include cloning kits, mutagenesis kits, and other related tools. Cloning kits are specialized laboratory instruments designed to streamline the process of cloning specific DNA fragments or genes into a cloning vector. These kits are essential for various cloning experiments, including gene cloning, subcloning, site-directed mutagenesis, and library construction. Techniques such as blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, among others, are employed by academic and research institutions, biotechnology companies, and other entities engaged in molecular biology research.

Tariffs are impacting the cloning and mutagenesis market by increasing costs of imported enzymes, reagents, vectors, specialized plastics, and laboratory automation components. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces cost pressure on kit manufacturing and exports. These tariffs are raising research operating costs and procurement cycles. However, they are also supporting domestic reagent production, regional supplier expansion, and localized manufacturing of molecular biology tools.

The cloning and mutagenesis market research report is one of a series of new reports from The Business Research Company that provides cloning and mutagenesis market statistics, including cloning and mutagenesis industry global market size, regional shares, competitors with a cloning and mutagenesis market share, detailed cloning and mutagenesis market segments, market trends and opportunities, and any further data you may need to thrive in the cloning and mutagenesis industry. This cloning and mutagenesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cloning and mutagenesis market size has grown rapidly in recent years. It will grow from $3.54 billion in 2025 to $4.21 billion in 2026 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to expansion of academic research funding, growth of recombinant protein research, increasing use of genetic engineering tools, availability of standardized molecular biology kits, rise of biotech startup activity.

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $8.5 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing demand for gene function studies, expansion of synthetic biology applications, rising investments in therapeutic protein development, growing adoption of automated lab platforms, increasing focus on precision genome editing. Major trends in the forecast period include increasing adoption of high-fidelity cloning kits, rising use of site-directed mutagenesis techniques, growing demand for crispr-based editing tools, expansion of automated molecular biology workflows, enhanced focus on reproducibility and accuracy.

The cloning and mutagenesis market is anticipated to grow due to the increasing demand for personalized medicine. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the unique characteristics of each patient. Cloning and mutagenesis play crucial roles in various aspects of personalized medicine, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. This increasing demand for personalized medicine is a significant driver of the growth in the cloning and mutagenesis market.

Leading companies in the cloning and mutagenesis markets are also actively exploring innovative techniques such as Polymerase Chain Reaction (PCR) to maintain a competitive edge. PCR is a molecular biology laboratory technique that amplifies specific DNA segments. Bio-Rad Laboratories, Inc., a US-based biotech company, launched the ID-Check Speciation Solution in April 2023. This real-time PCR method aids in meat speciation, allowing the identification of animal species in food, feed, and environmental samples. It provides a reliable and rapid means to verify raw material origins, enhancing production line cleaning processes. The solution targets mitochondrial DNA from various meat species with exceptional sensitivity, detecting DNA concentrations as low as 0.001%. It features a duplex detection system for accuracy and user convenience.

n March 2023, Sartorius AG, a Germany-based multinational life science company, acquired Polyplus Transfection SA for an undisclosed amount. Through this acquisition, Sartorius intends to broaden its upstream portfolio for cell and gene therapy manufacturing by incorporating Polyplus's transfection reagents, nucleic acid delivery technologies, and GMP-grade plasmid DNA capabilities to support viral vector production and plasmid workflows essential to gene modification research and GMP applications. Polyplus Transfection SA, a France-based company, offers services related to cloning and mutagenesis.

Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC

North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cloning and mutagenesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes of sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cloning And Mutagenesis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cloning and mutagenesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cloning and mutagenesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cloning and mutagenesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Cloning Kits; Mutagenesis Kits; Other Products
• 2) By Technique: Blunt End Cloning; Topo PCR Cloning; Seamless Cloning; Site-Directed Mutagenesis; Other Techniques
• 3) By End User: Academic and Research Institutes; Biotechnology Companies; Other End Users
• Subsegments:
• 1) By Cloning Kits: Bacterial Cloning Kits; Yeast Cloning Kits; Viral Cloning Kits; Plasmid Cloning Kits
• 2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits; Random Mutagenesis Kits; Error-Prone PCR Kits; CRISPR Or Cas9 Mutagenesis Kits
• 3) By Other Products: Enzymes; Vector Systems; Accessories
• Companies Mentioned: Thermo Fisher Scientific Inc; Takara Bio Inc; Agilent Technologies Inc; New England Biolabs Inc; Merck KGaA; Promega Corporation; Bio-Rad Laboratories Inc; GenScript Biotech Corporation; Codex DNA Inc; Integrated DNA Technologies Inc; Bio-Techne Corporation; Sino Biological Inc; OriGene Technologies Inc; Bioneer Corporation; Lucigen Corporation; Inscripta Inc; Creative Biogene; Biomatik Corporation; TransGen Biotech Co Ltd; Jena Bioscience GmbH; EZBioscience; Synbio Technologies LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cloning And Mutagenesis Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cloning And Mutagenesis Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cloning And Mutagenesis Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cloning And Mutagenesis Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics And Precision Medicine
  • 4.1.2 Artificial Intelligence And Autonomous Intelligence
  • 4.1.3 Industry 4.0 And Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data And Cybersecurity
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of High-Fidelity Cloning Kits
  • 4.2.2 Rising Use Of Site-Directed Mutagenesis Techniques
  • 4.2.3 Growing Demand For Crispr-Based Editing Tools
  • 4.2.4 Expansion Of Automated Molecular Biology Workflows
  • 4.2.5 Enhanced Focus On Reproducibility And Accuracy

5. Cloning And Mutagenesis Market Analysis Of End Use Industries

• 5.1 Academic And Research Institutes
• 5.2 Biotechnology Companies
• 5.3 Pharmaceutical Companies
• 5.4 Contract Research Organizations
• 5.5 Synthetic Biology Firms

6. Cloning And Mutagenesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cloning And Mutagenesis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cloning And Mutagenesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cloning And Mutagenesis Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cloning And Mutagenesis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cloning And Mutagenesis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cloning And Mutagenesis Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cloning And Mutagenesis Market Segmentation

• 9.1. Global Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cloning Kits, Mutagenesis Kits, Other Products
• 9.2. Global Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques, CRISPR-Based Editing
• 9.3. Global Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Academic And Research Institutes, Biotechnology Companies, Other End Users
• 9.4. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Cloning Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits
• 9.5. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Mutagenesis Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits
• 9.6. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enzymes, Vector Systems, Accessories

10. Cloning And Mutagenesis Market Regional And Country Analysis

• 10.1. Global Cloning And Mutagenesis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cloning And Mutagenesis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cloning And Mutagenesis Market

• 11.1. Asia-Pacific Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cloning And Mutagenesis Market

• 12.1. China Cloning And Mutagenesis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cloning And Mutagenesis Market

• 13.1. India Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cloning And Mutagenesis Market

• 14.1. Japan Cloning And Mutagenesis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cloning And Mutagenesis Market

• 15.1. Australia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cloning And Mutagenesis Market

• 16.1. Indonesia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cloning And Mutagenesis Market

• 17.1. South Korea Cloning And Mutagenesis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cloning And Mutagenesis Market

• 18.1. Taiwan Cloning And Mutagenesis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cloning And Mutagenesis Market

• 19.1. South East Asia Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cloning And Mutagenesis Market

• 20.1. Western Europe Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cloning And Mutagenesis Market

• 21.1. UK Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cloning And Mutagenesis Market

• 22.1. Germany Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cloning And Mutagenesis Market

• 23.1. France Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cloning And Mutagenesis Market

• 24.1. Italy Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cloning And Mutagenesis Market

• 25.1. Spain Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cloning And Mutagenesis Market

• 26.1. Eastern Europe Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cloning And Mutagenesis Market

• 27.1. Russia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cloning And Mutagenesis Market

• 28.1. North America Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cloning And Mutagenesis Market

• 29.1. USA Cloning And Mutagenesis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cloning And Mutagenesis Market

• 30.1. Canada Cloning And Mutagenesis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cloning And Mutagenesis Market

• 31.1. South America Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cloning And Mutagenesis Market

• 32.1. Brazil Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cloning And Mutagenesis Market

• 33.1. Middle East Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cloning And Mutagenesis Market

• 34.1. Africa Cloning And Mutagenesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cloning And Mutagenesis Market Regulatory and Investment Landscape

36. Cloning And Mutagenesis Market Competitive Landscape And Company Profiles

• 36.1. Cloning And Mutagenesis Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cloning And Mutagenesis Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cloning And Mutagenesis Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Takara Bio Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. New England Biolabs Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Cloning And Mutagenesis Market Other Major And Innovative Companies

• Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH

38. Global Cloning And Mutagenesis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cloning And Mutagenesis Market

40. Cloning And Mutagenesis Market High Potential Countries, Segments and Strategies

• 40.1 Cloning And Mutagenesis Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cloning And Mutagenesis Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cloning And Mutagenesis Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer